This contract expires in 389 days (May 15, 2027).

Browse related active opportunities

FIRM FIXED PRICENO SET ASIDE USED.

BIOCARTIS US INC - CPT - CANCER REAGENTS/IDYLLA

PIID: 36C24722P0776Solicitation ID: 36C24722Q0405
Signed Date: Feb 5, 2026Effective Date: May 16, 2022End Date: Closes in 389 days

Key Details

Dollars Obligated
$113,841.5
Base & All Options
Awarding Sub-Agency
Department of Veterans Affairs
Product Service Code
6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Extent Competed
NOT COMPETED
Number of Offers
1
Place of Performance
JERSEY CITY, NJ, 073023834, CD-NJ-08

Description

CPT - CANCER REAGENTS/IDYLLA

Context & Analysis

On Feb 5, 2026, Department of Veterans Affairs obligated $113,841.5 to BIOCARTIS US INC for cpt - cancer reagents/idylla. The award is classified under NAICS 325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING and issued as a firm fixed price contract. Competition extent: not competed with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in JERSEY CITY, NJ. The contract is scheduled through May 15, 2027 — approximately 13 months remaining. This award is one of several similar procurements from Department of Veterans Affairs under NAICS 325413 — related awards are listed below.

Contractor Information

Contractor: BIOCARTIS US INC
UEI: RY27EUE8U9B7
CAGE Code: 8FD63
Location: JERSEY CITY, NJ
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related